MicroRNA-133a: A Novel Cardioprotective Agent in Diabetic Cardiomyopathy

Exploring microRNA-133a as a novel therapy, our lab addresses diabetic cardiomyopathy. This approach shows potential in improving heart function and reducing damage in diabetic hearts.

MMP9: Targeting a Key Enzyme in Diabetic Heart Disease

Exploring MMP9 in diabetic hearts, our project examines its role in heart disease progression. Aiming to develop MMP9 inhibitors, we seek new treatments for diabetic cardiomyopathy.

Hydrogen Sulfide in Diabetic Cardiomyopathy: A Potential Cardioprotective Therapy

Exploring reduced hydrogen sulfide (H2S) in diabetic hearts, our study tests H2S supplementation as a therapy to protect and improve cardiac health in diabetes